Shares of Mankind Pharma Ltd saw a significant rebound, rising 3.87% to ₹2,630.20 on the NSE after five consecutive sessions of decline. This recovery comes after the stock dropped by 3.22% the previous day to ₹2,537.6. Despite recent volatility, Mankind Pharma has shown impressive growth over the past year, with a 23.9% increase compared to a 20.25% rise in the NIFTY and a 40.48% gain in the Nifty Pharma index.
Key Highlights:
- Recent Performance: Mankind Pharma shares dropped around 8.04% over the past month. Meanwhile, the Nifty Pharma index, of which it is a constituent, has declined by approximately 7.95%.
- Market Context: The overall market saw some weakness yesterday, with the NIFTY down 0.94% and Sensex down 0.83%.
- Volume Activity: Today’s volume in Mankind Pharma was at 2.1 lakh shares, below the one-month daily average of 3.25 lakh shares, indicating cautious investor activity amidst the rebound.
This recovery in Mankind Pharma shares signals a potential renewed interest from investors after a brief period of profit-taking and sector-wide correction. The stock remains one to watch as it stabilizes and potentially regains upward momentum.
